[Osteoarticular manifestations of Gaucher disease in adults: pathophysiology and treatment].
Hachulla
E
E
Service de Médecine Interne, Hôpital Claude Huriez, Centre National de Référence "Maladies Métaboliques Rares de l'enfant et de l'adulte coordonné par le Dr D. Dobbelaere", 59037 Lille, France. ehachulla@chru-lille.fr
Javier
R M
RM
D017485:1-Deoxynojirimycin / Q000008:administration & dosage / Q000031:analogs & derivatives / Q000627:therapeutic use; D000328:Adult; D015519:Bone Density; D001847:Bone Diseases / Q000175:diagnosis / Q000209:etiology*; D004164:Diphosphonates / Q000627:therapeutic use; D004791:Enzyme Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use; D005776:Gaucher Disease / Q000145:classification / Q000150:complications* / Q000188:drug therapy / Q000235:genetics; D005838:Genotype; D005962:Glucosylceramidase / Q000008:administration & dosage / Q000627:therapeutic use; D065089:Glycoside Hydrolase Inhibitors; D006801:Humans; D007592:Joint Diseases / Q000175:diagnosis / Q000209:etiology*; D008279:Magnetic Resonance Imaging; D010020:Osteonecrosis / Q000209:etiology; D011788:Quality of Life; D011994:Recombinant Proteins / Q000008:administration & dosage / Q000627:therapeutic use; D012042:Registries; D013997:Time Factors; D016896:Treatment Outcome
D004164:Diphosphonates; D004791:Enzyme Inhibitors; D065089:Glycoside Hydrolase Inhibitors; D011994:Recombinant Proteins; D017485:1-Deoxynojirimycin; C070292:alglucerase; C059896:miglustat; D005962:Glucosylceramidase; C090568:imiglucerase